medline.ch Gynäkologie Mammae

	The fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection in Chinese patients with HER2-positive early breast cancer: primary analysis of the phase III, randomized FDChina study. Int J Clin Oncol Huang T, Fan Z, Wang Y, Yan X, Yang H, Wang S, Pang D, Li H, Wang H, Geng C, Huang L, Sun Y, Wang B, Sun G, Siddiqui A, Restuccia E, Shao Z. PMID: 42098463 [PubMed - as supplied by publisher]
	The impact of online-delivered controlled physical activity on cardiorespiratory fitness and heart rate variability in breast cancer survivors. Sci Rep Bohovicová L, , Bure, Palácová M, Petráková K, Gescheidtová L, , Kiss I, Bazalová P, Hrn, , Halámková J. PMID: 42098205 [PubMed - as supplied by publisher]
	A chemotherapy-free, pathological response-adapted strategy using trastuzumab-pertuzumab and T-DM1 in HER2-positive early breast cancer: the PHERGain-2 study. Ann Oncol Garrigós L, Ruiz-Borrego M, Pérez-García JM, Guerrero-Zotano A, Cortés-Salgado A, Kuemmel S, Colleoni M, Reboredo-Rendo C, Bermejo B, Blancas I, Gavila J, Fabi A, Morales C, Stradella A, Carañana V, Martínez-de Dueñas E, Albacar C, Ballesteros-Cidras O, Martrat G, Iacobucci S, Boix O, Berenguer-Molins P, Alcalá-López D, Cortés J, Llombart-Cussac A, PHERGain-2 investigators. PMID: 42097893 [PubMed - as supplied by publisher]
	What is the adherence to an exercise intervention during (neo-)adjuvant chemotherapy among Swedish patients with breast cancer? Data from the Phys-Can randomised controlled trial. BMJ Open Henriksson A, Stenling A, Mazzoni AS, Sjövall K, Börjeson S, Berntsen S, Bean CG, Buffart LM, Nordin K, Demmelmaier I. PMID: 42097659 [PubMed - indexed for MEDLINE]
	Examining the Influence of Social Network Factors on Weight Loss Among Latina and Non-Hispanic White Breast Cancer Survivors: Observational Cohort Study. JMIR Form Res Janio E, Hoyt MA, Biegler KA, Al-Majid S, Chen Y, Kobsa A, Sorkin DH. PMID: 42097613 [PubMed - indexed for MEDLINE]
	In silico studies, synthesis, and biological evaluation of novel imidazopyridine-based CYP4Z1 inhibitors targeting breast cancer stem cells. Eur J Med Chem Lu Y, Chen K, Wang H, Zhang C, Huang X, Wang Z, Chen H, Niu M, Yao H, Zheng L, Xu S, Guo Q. PMID: 42097058 [PubMed - as supplied by publisher]
	NOS2 and COX2 impact the spatial landscape of CD8(+) T cells in ER-breast cancer, providing novel mechanistic insight that drives tumor progression and poor survival. Redox Biol Ridnour LA, Cheng RY, Heinz WF, Coutinho LL, Palmieri EM, Rangel MC, Anderson SK, McVicar DW, Hewitt SM, Wong ST, Li X, Ambs S, Billiar TR, Glynn SA, Chang JC, Lockett SJ, Wink DA. PMID: 42097035 [PubMed - as supplied by publisher]
	Precision nutrition in breast cancer: Towards patient- and tumour-informed dietary strategies. Clin Nutr Crespo-García C, Taaffe DR, Peddle-McIntyre CJ, Jeffery E, Campbell JP, Thomas R, Galvao DA, Newton RU. PMID: 42096978 [PubMed - as supplied by publisher]
	Experiences and challenges in implant based breast reconstruction decision making among young breast cancer patients: A qualitative study. Acta Psychol (Amst) Gao Y, Liu S, Shen Y, Shen M, Liu J, Ning L, Cai L. PMID: 42096952 [PubMed - as supplied by publisher]
	New pyrimidine compounds as potent anti-breast cancer agents: synthesis, biological evaluation and computational studies. Bioorg Chem Sutar NR, Alegaon SG, Gharge S, Ranade SD, Kamble PA. PMID: 42096928 [PubMed - as supplied by publisher]
	A multicenter study on microsurgical procedures to treat congenital and acquired breast abnormalities. J Plast Reconstr Aesthet Surg Grünherz L, Weitgasser L, Mahrhofer M, Musmann RJ, Fertsch S, Wolter A, Munder B, Andree C, Lindenblatt N, Schoeller T, Kneser U, Siegwart LC. PMID: 42096764 [PubMed - as supplied by publisher]
	Right-Sizing Locoregional Management in the Era of Neoadjuvant Therapy for Breast Cancer. Am Soc Clin Oncol Educ Book Wong SM, Speers C, Schaverien MV. PMID: 42096667 [PubMed - indexed for MEDLINE]
	Autoencoder/RandomForest-TabPFN for Cross-Cancer Metabolomics: Prostate and Breast Cancer Diagnosis Using Paper Spray and Ion Mobility-Mass Spectrometry Techniques. Gigascience Hauns S, Pinto FG, Khyriem C, Singh A, Al-Sadi A, Yazeedi TA, Mohammad R, Cisse B, Garrett TJ, Uddin M, Soares NC, Backofen R, Alkhnbashi OS. PMID: 42096511 [PubMed - as supplied by publisher]
	Correction: Evaluation of Large Language Models for Radiologists' Support in Multidisciplinary Breast Cancer Teams: Comparative Study. JMIR Med Inform Jiang H, Yang C, Zhou W, Yin CL, Zhou S, He R, Ran G, Wang W, Wu M, Yu J. PMID: 42096260 [PubMed - in process]
	Identification of RPL4 as a biomarker associated with disulfidptosis and arachidonic acid metabolism in breast cancer. Discov Oncol Yan T, Yu B, Qian F, Fang L, Zhao Y, Ye D. PMID: 42096008 [PubMed - as supplied by publisher]
	Deep learning model for noninvasive prediction of Ki-67 expression and prognostic stratification in breast cancer: a multicenter retrospective study. Eur Radiol Yu W, Chen P, Chai S, Ding W, Zhang L. PMID: 42095876 [PubMed - as supplied by publisher]
	Chest Wall Perforator Flaps in Breast Cancer Surgery: A Systematic Review of Clinical Outcomes, Complications, and Patient-Reported Satisfaction. World J Surg Yadav SK, S D, Sethi S, Azhar T, Abdurahman A, Agrawal SK. PMID: 42095770 [PubMed - as supplied by publisher]
	Concordance between automated/semi-automated measurement and manual assessment of mammographic breast density in individuals undergoing breast cancer screening: A systematic review. J Med Screen Robertson C, Cooper D, Duggan SN, Manson P, Imamura M, Hernández R, Clarke M, Treweek S, Brazzelli M. PMID: 42095690 [PubMed - as supplied by publisher]
	Response to letter regarding "relationship between menopausal hormone therapy and incidence risk of breast cancer: systematic review and meta-analysis". Ann Med Wu Q, Dai Z. PMID: 42095437 [PubMed - in process]
	Ten-year subtype survival and systemic-therapy pathways analysis after breast-cancer recurrence in the LACRN MPBC multicountry cohort study. Lancet Reg Health Am Retamales J, Araya I, Abdelhay E, Acosta Torres KT, Alves da Quinta D, Alcoba E, Alonso I, Artagaveytia N, Binato R, Bravo AI, Bustos-Rodriguez F, Camejo N, Carraro DM, Castro M, Cataldi S, Cerda M, Chiquitelli Marques Silveira MM, Crocamo S, Daneri-Navarro A, Del Toro-Arreola A, Franco-Topete R, Gaete F, Gomez J, Guerra R, Hannois A, Llera AS, Lopez-Vazquez A, Moran-Mendoza A, Nagai MA, Oceguera-Villanueva A, Podhajcer O, Quintero-Ramos A, Rosales C, Saavedra E, Seguel O, Sierra C, Sanchotena V, Savignano M, Tejeda-Moctezuma R, Trinchero A, Valenzuela B, Velazquez C, Villalobos M, Vilensky M, Zagame L, Zlatar Z, Müller B, Latin American Cancer Research Network (LACRN) Investigators. PMID: 42095205 [PubMed]

Artikel 1 - 20 / 217368

Seite 1 von 10869

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung